{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:18Z","timestamp":1772119998583,"version":"3.50.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:00:00Z","timestamp":1698105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:00:00Z","timestamp":1698105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["1443_11-1"],"award-info":[{"award-number":["1443_11-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KN 590\/9-1"],"award-info":[{"award-number":["KN 590\/9-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK 2606"],"award-info":[{"award-number":["GRK 2606"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eucor - The European Campus"},{"name":"Federal Ministry of Economics, Science and Arts of Baden-W\u00fcrttemberg","award":["BrainLinks-BrainTools"],"award-info":[{"award-number":["BrainLinks-BrainTools"]}]},{"name":"Federal Ministry of Economics, Science and Arts of Baden-W\u00fcrttemberg","award":["BrainLinks-BrainTools"],"award-info":[{"award-number":["BrainLinks-BrainTools"]}]},{"name":"Research commission of the Medical Faculty, University of Freiburg"},{"name":"Scientific Community, University of Freiburg"},{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Structural epilepsies display complex immune activation signatures. However, it is unclear which neuroinflammatory pathways drive pathobiology. Transcriptome studies of brain resections from mesial temporal lobe epilepsy (mTLE) patients revealed a dysregulation of transforming growth factor \u03b2, interferon \u03b1\/\u03b2, and nuclear factor erythroid 2-related factor 2 pathways. Since these pathways are regulated by ubiquitin-specific proteases (USP), in particular USP15, we hypothesized that USP15 blockade may provide therapeutic relief in treatment-resistant epilepsies. For validation, transgenic mice which either constitutively or inducibly lack Usp15 gene expression underwent intrahippocampal kainate injections to induce mTLE. We show that the severity of\n                    <jats:italic>status epilepticus<\/jats:italic>\n                    is unaltered in mice constitutively lacking Usp15 compared to wild types. Cell death, reactive gliosis, and changes in the inflammatory transcriptome were pronounced at 4\u00a0days after kainate injection. However, these brain inflammation signatures did not differ between genotypes. Likewise, induced deletion of Usp15 in chronic epilepsy did not affect seizure generation, cell death, gliosis, or the transcriptome. Concordantly, siRNA-mediated knockdown of Usp15 in a microglial cell line did not impact inflammatory responses in the form of cytokine release. Our data show that a lack of USP15 is insufficient to modulate the expression of relevant neuroinflammatory pathways in an mTLE mouse model and do not support targeting USP15 as a therapeutic approach for pharmacoresistant epilepsy.\n                  <\/jats:p>","DOI":"10.1007\/s12035-023-03692-2","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T03:02:30Z","timestamp":1698116550000},"page":"2367-2389","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Downregulation of Ubiquitin-Specific Protease 15 (USP15) Does Not Provide Therapeutic Benefit in Experimental Mesial Temporal Lobe Epilepsy"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5601-9833","authenticated-orcid":false,"given":"Ute","family":"H\u00e4ussler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4488-2423","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Neres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Vandenplas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9894-2586","authenticated-orcid":false,"given":"Caroline","family":"Eykens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Kadiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2274-3393","authenticated-orcid":false,"given":"Renaud","family":"Fleurance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6257-9730","authenticated-orcid":false,"given":"Patrice","family":"Godard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3821-1957","authenticated-orcid":false,"given":"Laurane","family":"de Mot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9949-0526","authenticated-orcid":false,"given":"Jonathan","family":"van Eyll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1587-1944","authenticated-orcid":false,"given":"Klaus-Peter","family":"Knobeloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7022-4136","authenticated-orcid":false,"given":"Carola A.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4869-1923","authenticated-orcid":false,"given":"Stefanie","family":"Dedeurwaerdere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,24]]},"reference":[{"issue":"9516","key":"3692_CR1","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0140-6736(06)68477-8","volume":"367","author":"JS Duncan","year":"2006","unstructured":"Duncan JS, Sander JW, Sisodiya SM, Walker MC (2006) Adult epilepsy. Lancet 367(9516):1087\u20131100. https:\/\/doi.org\/10.1016\/S0140-6736(06)68477-8","journal-title":"Lancet"},{"issue":"10","key":"3692_CR2","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1111\/epi.17022","volume":"62","author":"G Giussani","year":"2021","unstructured":"Giussani G, Bianchi E, Beretta S, Carone D, DiFrancesco JC, Stabile A et al (2021) Comorbidities in patients with epilepsy: frequency, mechanisms and effects on long-term outcome. Epilepsia 62(10):2395\u20132404. https:\/\/doi.org\/10.1111\/epi.17022","journal-title":"Epilepsia"},{"issue":"4","key":"3692_CR3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/epi.13670","volume":"58","author":"RS Fisher","year":"2017","unstructured":"Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE et al (2017) Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58(4):522\u2013530. https:\/\/doi.org\/10.1111\/epi.13670","journal-title":"Epilepsia"},{"issue":"4","key":"3692_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L et al (2017) ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58(4):512\u2013521. https:\/\/doi.org\/10.1111\/epi.13709","journal-title":"Epilepsia"},{"key":"3692_CR5","doi-asserted-by":"publisher","first-page":"674483","DOI":"10.3389\/fneur.2021.674483","volume":"12","author":"A Fattorusso","year":"2021","unstructured":"Fattorusso A, Matricardi S, Mencaroni E, Dell\u2019Isola GB, Di Cara G, Striano P et al (2021) The pharmacoresistant epilepsy: an overview on existant and new emerging therapies. Front Neurol 12:674483. https:\/\/doi.org\/10.3389\/fneur.2021.674483","journal-title":"Front Neurol"},{"key":"3692_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.eplepsyres.2017.09.012","volume":"137","author":"MS Pohlen","year":"2017","unstructured":"Pohlen MS, Jin J, Tobias RS, Maheshwari A (2017) Pharmacoresistance with newer anti-epileptic drugs in mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsy Res 137:56\u201360. https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.09.012","journal-title":"Epilepsy Res"},{"issue":"5","key":"3692_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/epi.13368","volume":"57","author":"M Chipaux","year":"2016","unstructured":"Chipaux M, Szurhaj W, Vercueil L, Milh M, Villeneuve N, Cances C et al (2016) Epilepsy diagnostic and treatment needs identified with a collaborative database involving tertiary centers in France. Epilepsia 57(5):757\u2013769. https:\/\/doi.org\/10.1111\/epi.13368","journal-title":"Epilepsia"},{"key":"3692_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.seizure.2018.09.020","volume":"62","author":"F Conte","year":"2018","unstructured":"Conte F, Legros B, Van Paesschen W, Avbersek A, Muglia P, Depondt C (2018) Long-term seizure outcomes in patients with drug resistant epilepsy. Seizure 62:74\u201378. https:\/\/doi.org\/10.1016\/j.seizure.2018.09.020","journal-title":"Seizure"},{"issue":"6","key":"3692_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.seizure.2014.03.003","volume":"23","author":"J S\u00e0nchez","year":"2014","unstructured":"S\u00e0nchez J, Centanaro M, Sol\u00eds J, Delgado F, Y\u00e9pez L (2014) Factors predicting the outcome following medical treatment of mesial temporal epilepsy with hippocampal sclerosis. Seizure 23(6):448\u2013453. https:\/\/doi.org\/10.1016\/j.seizure.2014.03.003","journal-title":"Seizure"},{"issue":"10","key":"3692_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrd4126","volume":"12","author":"W L\u00f6scher","year":"2013","unstructured":"L\u00f6scher W, Klitgaard H, Twyman RE, Schmidt D (2013) New avenues for anti-epileptic drug discovery and development. Nat Rev Drug Discov 12(10):757\u2013776. https:\/\/doi.org\/10.1038\/nrd4126","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"3692_CR11","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1528-1167.2012.03520.x","volume":"53","author":"S Dedeurwaerdere","year":"2012","unstructured":"Dedeurwaerdere S, Friedman A, Fabene PF, Mazarati A, Murashima YL, Vezzani A et al (2012) Finding a better drug for epilepsy: antiinflammatory targets. Epilepsia 53(7):1113\u20131118. https:\/\/doi.org\/10.1111\/j.1528-1167.2012.03520.x","journal-title":"Epilepsia"},{"key":"3692_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nbd.2016.12.007","volume":"99","author":"V Iori","year":"2017","unstructured":"Iori V, Iyer AM, Ravizza T, Beltrame L, Paracchini L, Marchini S et al (2017) Blockade of the IL-1R1\/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy. Neurobiol Dis 99:12\u201323. https:\/\/doi.org\/10.1016\/j.nbd.2016.12.007","journal-title":"Neurobiol Dis"},{"issue":"Suppl 3","key":"3692_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/epi.13783","volume":"58","author":"E Aronica","year":"2017","unstructured":"Aronica E, Bauer S, Bozzi Y, Caleo M, Dingledine R, Gorter JA et al (2017) Neuroinflammatory targets and treatments for epilepsy validated in experimental models. Epilepsia 58(Suppl 3):27\u201338. https:\/\/doi.org\/10.1111\/epi.13783","journal-title":"Epilepsia"},{"issue":"1","key":"3692_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/nan.12444","volume":"44","author":"EA van Vliet","year":"2018","unstructured":"van Vliet EA, Aronica E, Vezzani A, Ravizza T (2018) Review: neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies. Neuropathol Appl Neurobiol 44(1):91\u2013111. https:\/\/doi.org\/10.1111\/nan.12444","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"3692_CR15","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3390\/brainsci11050663","volume":"11","author":"ED Bazhanova","year":"2021","unstructured":"Bazhanova ED, Kozlov AA, Litovchenko AV (2021) Mechanisms of drug resistance in the pathogenesis of epilepsy: role of neuroinflammation a literature review. Brain Sci. 11(5):663. https:\/\/doi.org\/10.3390\/brainsci11050663","journal-title":"Brain Sci."},{"issue":"3","key":"3692_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.nbd.2007.01.015","volume":"26","author":"E Aronica","year":"2007","unstructured":"Aronica E, Boer K, van Vliet EA, Redeker S, Baayen JC, Spliet WGM et al (2007) Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 26(3):497\u2013511. https:\/\/doi.org\/10.1016\/j.nbd.2007.01.015","journal-title":"Neurobiol Dis"},{"issue":"1","key":"3692_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.nbd.2007.08.012","volume":"29","author":"T Ravizza","year":"2008","unstructured":"Ravizza T, Gagliardi B, No\u00e9 F, Boer K, Aronica E, Vezzani A (2008) Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29(1):142\u2013160. https:\/\/doi.org\/10.1016\/j.nbd.2007.08.012","journal-title":"Neurobiol Dis"},{"issue":"1\u20132","key":"3692_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2010.06.002","volume":"296","author":"T Yang","year":"2010","unstructured":"Yang T, Zhou D, Stefan H (2010) Why mesial temporal lobe epilepsy with hippocampal sclerosis is progressive: uncontrolled inflammation drives disease progression? J Neurol Sci 296(1\u20132):1\u20136. https:\/\/doi.org\/10.1016\/j.jns.2010.06.002","journal-title":"J Neurol Sci"},{"key":"3692_CR19","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.nbd.2015.09.004","volume":"82","author":"H Amhaoul","year":"2015","unstructured":"Amhaoul H, Hamaide J, Bertoglio D, Reichel SN, Verhaeghe J, Geerts E et al (2015) Brain inflammation in a chronic epilepsy model: evolving pattern of the translocator protein during epileptogenesis. Neurobiol Dis 82:526\u2013539. https:\/\/doi.org\/10.1016\/j.nbd.2015.09.004","journal-title":"Neurobiol Dis"},{"issue":"1","key":"3692_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd.2017.152","volume":"17","author":"JA Harrigan","year":"2018","unstructured":"Harrigan JA, Jacq X, Martin NM, Jackson SP (2018) Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov 17(1):57\u201378. https:\/\/doi.org\/10.1038\/nrd.2017.152","journal-title":"Nat Rev Drug Discov"},{"issue":"Pt 2","key":"3692_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.semcancer.2020.03.008","volume":"67","author":"T Bonacci","year":"2020","unstructured":"Bonacci T, Emanuele MJ (2020) Dissenting degradation: deubiquitinases in cell cycle and cancer. Semin Cancer Biol 67(Pt 2):145\u2013158. https:\/\/doi.org\/10.1016\/j.semcancer.2020.03.008","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"3692_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41419-020-03361-5","volume":"12","author":"F Amer-Sarsour","year":"2021","unstructured":"Amer-Sarsour F, Kordonsky A, Berdichevsky Y, Prag G, Ashkenazi A (2021) Deubiquitylating enzymes in neuronal health and disease. Cell Death Dis 12(1):120. https:\/\/doi.org\/10.1038\/s41419-020-03361-5","journal-title":"Cell Death Dis"},{"issue":"1","key":"3692_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/ni.3581","volume":"18","author":"S Torre","year":"2017","unstructured":"Torre S, Polyak MJ, Langlais D, Fodil N, Kennedy JM, Radovanovic I et al (2017) USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation. Nat Immunol 18(1):54\u201363. https:\/\/doi.org\/10.1038\/ni.3581","journal-title":"Nat Immunol"},{"issue":"11","key":"3692_CR24","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1038\/ncb2346","volume":"13","author":"M Inui","year":"2011","unstructured":"Inui M, Manfrin A, Mamidi A, Martello G, Morsut L, Soligo S et al (2011) USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat Cell Biol 13(11):1368\u20131375. https:\/\/doi.org\/10.1038\/ncb2346","journal-title":"Nat Cell Biol"},{"issue":"3","key":"3692_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm.2619","volume":"18","author":"PJA Eichhorn","year":"2012","unstructured":"Eichhorn PJA, Rod\u00f3n L, Gonz\u00e0lez-Junc\u00e0 A, Dirac A, Gili M, Mart\u00ednez-S\u00e1ez E et al (2012) USP15 stabilizes TGF-\u03b2 receptor I and promotes oncogenesis through the activation of TGF-\u03b2 signaling in glioblastoma. Nat Med 18(3):429\u2013435. https:\/\/doi.org\/10.1038\/nm.2619","journal-title":"Nat Med"},{"issue":"1","key":"3692_CR26","doi-asserted-by":"publisher","first-page":"14733","DOI":"10.1038\/srep14733","volume":"5","author":"PV Iyengar","year":"2015","unstructured":"Iyengar PV, Jaynes P, Rodon L, Lama D, Law KP, Lim YP et al (2015) USP15 regulates SMURF2 kinetics through C-lobe mediated deubiquitination. Sci Rep 5(1):14733. https:\/\/doi.org\/10.1038\/srep14733","journal-title":"Sci Rep"},{"issue":"1","key":"3692_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.molcel.2013.04.022","volume":"51","author":"NF Villeneuve","year":"2013","unstructured":"Villeneuve NF, Tian W, Wu T, Sun Z, Lau A, Chapman E et al (2013) USP15 negatively regulates Nrf2 through deubiquitination of Keap1. Mol Cell 51(1):68\u201379. https:\/\/doi.org\/10.1016\/j.molcel.2013.04.022","journal-title":"Mol Cell"},{"issue":"1","key":"3692_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/s0006-8993(99)01328-1","volume":"835","author":"IL Campbell","year":"1999","unstructured":"Campbell IL, Krucker T, Steffensen S, Akwa Y, Powell HC, Lane T et al (1999) Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. Brain Res 835(1):46\u201361. https:\/\/doi.org\/10.1016\/s0006-8993(99)01328-1","journal-title":"Brain Res"},{"issue":"6","key":"3692_CR29","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1111\/j.1471-4159.2006.04019.x","volume":"98","author":"AD Kraft","year":"2006","unstructured":"Kraft AD, Lee JM, Johnson DA, Kan YW, Johnson JA (2006) Neuronal sensitivity to kainic acid is dependent on the Nrf2-mediated actions of the antioxidant response element. J Neurochem 98(6):1852\u20131865. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04019.x","journal-title":"J Neurochem"},{"issue":"4","key":"3692_CR30","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ana.23940","volume":"74","author":"M Mazzuferi","year":"2013","unstructured":"Mazzuferi M, Kumar G, van Eyll J, Danis B, Foerch P, Kaminski RM (2013) Nrf2 defense pathway: experimental evidence for its protective role in epilepsy. Ann Neurol 74(4):560\u2013568. https:\/\/doi.org\/10.1002\/ana.23940","journal-title":"Ann Neurol"},{"key":"3692_CR31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.eplepsyres.2018.08.004","volume":"146","author":"D Paul","year":"2018","unstructured":"Paul D, Dixit A, Srivastava A, Tripathi M, Prakash D, Sarkar C et al (2018) Altered transforming growth factor beta\/SMAD3 signalling in patients with hippocampal sclerosis. Epilepsy Res 146:144\u2013150. https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.08.004","journal-title":"Epilepsy Res"},{"issue":"7","key":"3692_CR32","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1046\/j.1460-9568.2000.00131.x","volume":"12","author":"E Aronica","year":"2000","unstructured":"Aronica E, van Vliet EA, Mayboroda OA, Troost D, da Silva FH, Gorter JA (2000) Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy. Eur J Neurosci 12(7):2333\u20132344. https:\/\/doi.org\/10.1046\/j.1460-9568.2000.00131.x","journal-title":"Eur J Neurosci"},{"issue":"28","key":"3692_CR33","doi-asserted-by":"publisher","first-page":"8927","DOI":"10.1523\/JNEUROSCI.0430-09.2009","volume":"29","author":"LP Cacheaux","year":"2009","unstructured":"Cacheaux LP, Ivens S, David Y, Lakhter AJ, Bar-Klein G, Shapira M et al (2009) Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J Neurosci 29(28):8927\u20138935. https:\/\/doi.org\/10.1523\/JNEUROSCI.0430-09.2009","journal-title":"J Neurosci"},{"issue":"6","key":"3692_CR34","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/ana.24147","volume":"75","author":"G Bar-Klein","year":"2014","unstructured":"Bar-Klein G, Cacheaux LP, Kamintsky L, Prager O, Weissberg I, Schoknecht K et al (2014) Losartan prevents acquired epilepsy via TGF-\u03b2 signaling suppression. Ann Neurol 75(6):864\u2013875. https:\/\/doi.org\/10.1002\/ana.24147","journal-title":"Ann Neurol"},{"issue":"1","key":"3692_CR35","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1038\/s41467-018-06008-4","volume":"9","author":"PK Srivastava","year":"2018","unstructured":"Srivastava PK, van Eyll J, Godard P, Mazzuferi M, Delahaye-Duriez A, Van Steenwinckel J et al (2018) A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target. Nat Commun 9(1):3561. https:\/\/doi.org\/10.1038\/s41467-018-06008-4","journal-title":"Nat Commun"},{"issue":"2","key":"3692_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1538\/expanim.55.137","volume":"55","author":"H Kanki","year":"2006","unstructured":"Kanki H, Suzuki H, Itohara S (2006) High-efficiency CAG-FLPe deleter mice in C57BL\/6J background. Exp Anim 55(2):137\u2013141. https:\/\/doi.org\/10.1538\/expanim.55.137","journal-title":"Exp Anim"},{"issue":"2","key":"3692_CR37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/dbio.2002.0597","volume":"244","author":"S Hayashi","year":"2002","unstructured":"Hayashi S, McMahon AP (2002) Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation\/inactivation in the mouse. Dev Biol 244(2):305\u2013318. https:\/\/doi.org\/10.1006\/dbio.2002.0597","journal-title":"Dev Biol"},{"issue":"24","key":"3692_CR38","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.1093\/nar\/23.24.5080","volume":"23","author":"F Schwenk","year":"1995","unstructured":"Schwenk F, Baron U, Rajewsky K (1995) A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 23(24):5080\u20135081. https:\/\/doi.org\/10.1093\/nar\/23.24.5080","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"3692_CR39","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1523\/JNEUROSCI.5516-05.2006","volume":"26","author":"C Heinrich","year":"2006","unstructured":"Heinrich C, Nitta N, Flubacher A, M\u00fcller M, Fahrner A et al (2006) Reelin deficiency and displacement of mature neurons, but not neurogenesis, underlie the formation of granule cell dispersion in the epileptic hippocampus. J Neurosci 26(17):4701\u20134713. https:\/\/doi.org\/10.1523\/JNEUROSCI.5516-05.2006","journal-title":"J Neurosci"},{"issue":"3","key":"3692_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","volume":"32","author":"RJ Racine","year":"1972","unstructured":"Racine RJ (1972) Modification of seizure activity by electrical stimulation: II. Motor Seizure Electroencephalogr Clin Neurophysiol 32(3):281\u2013294. https:\/\/doi.org\/10.1016\/0013-4694(72)90177-0","journal-title":"Motor Seizure Electroencephalogr Clin Neurophysiol"},{"issue":"6","key":"3692_CR41","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/epi.15540","volume":"60","author":"S Tulke","year":"2019","unstructured":"Tulke S, Haas CA, H\u00e4ussler U (2019) Expression of brain-derived neurotrophic factor and structural plasticity in the dentate gyrus and CA2 region correlate with epileptiform activity. Epilepsia 60(6):1234\u20131247. https:\/\/doi.org\/10.1111\/epi.15540","journal-title":"Epilepsia"},{"key":"3692_CR42","doi-asserted-by":"publisher","unstructured":"Heining K, Kilias A, Janz P, H\u00e4ussler U, Kumar A, Haas CA et al (2019) Bursts with high and low load of epileptiform spikes show context-dependent correlations in epileptic mice. eNeuro 6(5). https:\/\/doi.org\/10.1523\/ENEURO.0299-18.2019","DOI":"10.1523\/ENEURO.0299-18.2019"},{"key":"3692_CR43","unstructured":"Franklin K, Paxinos G (2007) The mouse brain in stereotaxic coordinates (Third Edition ed.): Academic Press"},{"issue":"4","key":"3692_CR44","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C (2017) Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods 14(4):417\u2013419. https:\/\/doi.org\/10.1038\/nmeth.4197","journal-title":"Nat Methods"},{"key":"3692_CR45","doi-asserted-by":"crossref","unstructured":"Soneson C, Love MI, Robinson MD (2015) Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res 4:1521","DOI":"10.12688\/f1000research.7563.1"},{"issue":"3","key":"3692_CR46","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, Oshlack A (2010) A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 11(3):R25. https:\/\/doi.org\/10.1186\/gb-2010-11-3-r25","journal-title":"Genome Biol"},{"issue":"15","key":"3692_CR47","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1093\/nar\/gkv412","volume":"43","author":"R Liu","year":"2015","unstructured":"Liu R, Holik AZ, Su S, Jansz N, Chen K, Leong HS et al (2015) Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses. Nucleic Acids Res 43(15):e97. https:\/\/doi.org\/10.1093\/nar\/gkv412","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"3692_CR48","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W et al (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"key":"3692_CR49","doi-asserted-by":"publisher","unstructured":"Korotkevich G, Sukhov V, Budin N, Shpak B, Artyomov MN, Sergushichev A (2021) Fast gene set enrichment analysis. bioRxiv. 060012. https:\/\/doi.org\/10.1101\/060012","DOI":"10.1101\/060012"},{"issue":"2","key":"3692_CR50","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1186\/gb-2007-8-2-r19","volume":"8","author":"J Hellemans","year":"2007","unstructured":"Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8(2):R19. https:\/\/doi.org\/10.1186\/gb-2007-8-2-r19","journal-title":"Genome Biol"},{"key":"3692_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fncel.2013.00167","volume":"7","author":"M Marx","year":"2013","unstructured":"Marx M, Haas CA, H\u00e4ussler U (2013) Differential vulnerability of interneurons in the epileptic hippocampus. Front Cell Neurosci 7:167. https:\/\/doi.org\/10.3389\/fncel.2013.00167","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"3692_CR52","doi-asserted-by":"publisher","first-page":"e1002466","DOI":"10.1371\/journal.pbio.1002466","volume":"14","author":"O Abiega","year":"2016","unstructured":"Abiega O, Beccari S, Diaz-Aparicio I, Nadjar A, Lay\u00e9 S, Leyrolle Q et al (2016) Neuronal hyperactivity disturbs ATP microgradients, impairs microglial motility, and reduces phagocytic receptor expression triggering apoptosis\/microglial phagocytosis uncoupling. PLoS Biol 14(5):e1002466. https:\/\/doi.org\/10.1371\/journal.pbio.1002466","journal-title":"PLoS Biol"},{"key":"3692_CR53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.7554\/eLife.25742","volume":"26","author":"P Janz","year":"2017","unstructured":"Janz P, Schwaderlapp N, Heining K, H\u00e4ussler U, Korvink JG, von Elverfeldt D et al (2017) Early tissue damage and microstructural reorganization predict disease severity in experimental epilepsy. Elife 26:6. https:\/\/doi.org\/10.7554\/eLife.25742","journal-title":"Elife"},{"key":"3692_CR54","doi-asserted-by":"publisher","unstructured":"Bouilleret V, Ridoux V, Depaulis A, Marescaux C, Nehlig A, Le Gal La Salle G (1999) Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy. Neuroscience 89(3):717\u201329. https:\/\/doi.org\/10.1016\/s0306-4522(98)00401-1","DOI":"10.1016\/s0306-4522(98)00401-1"},{"issue":"1","key":"3692_CR55","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.expneurol.2012.04.009","volume":"236","author":"M Bechstein","year":"2012","unstructured":"Bechstein M, H\u00e4ussler U, Neef M, Hofmann HD, Kirsch M, Haas CA (2012) CNTF-mediated preactivation of astrocytes attenuates neuronal damage and epileptiform activity in experimental epilepsy. Exp Neurol 236(1):141\u2013150. https:\/\/doi.org\/10.1016\/j.expneurol.2012.04.009","journal-title":"Exp Neurol"},{"issue":"1","key":"3692_CR56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/cercor\/bhr054","volume":"22","author":"U H\u00e4ussler","year":"2012","unstructured":"H\u00e4ussler U, Bielefeld L, Froriep UP, Wolfart J, Haas CA (2012) Septotemporal position in the hippocampal formation determines epileptic and neurogenic activity in temporal lobe epilepsy. Cereb Cortex 22(1):26\u201336. https:\/\/doi.org\/10.1093\/cercor\/bhr054","journal-title":"Cereb Cortex"},{"issue":"12","key":"3692_CR57","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1111\/j.1528-1167.2011.03273.x","volume":"52","author":"F Pernot","year":"2011","unstructured":"Pernot F, Heinrich C, Barbier L, Peinnequin A, Carpentier P, Dhote F et al (2011) Inflammatory changes during epileptogenesis and spontaneous seizures in a mouse model of mesiotemporal lobe epilepsy. Epilepsia 52(12):2315\u20132325. https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03273.x","journal-title":"Epilepsia"},{"issue":"5","key":"3692_CR58","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.stem.2015.04.003","volume":"16","author":"A Sierra","year":"2015","unstructured":"Sierra A, Mart\u00edn-Su\u00e1rez S, Valc\u00e1rcel-Mart\u00edn R, Pascual-Brazo J, Aelvoet SA, Abiega O et al (2015) Neuronal hyperactivity accelerates depletion of neural stem cells and impairs hippocampal neurogenesis. Cell Stem Cell 16(5):488\u2013503. https:\/\/doi.org\/10.1016\/j.stem.2015.04.003","journal-title":"Cell Stem Cell"},{"issue":"6","key":"3692_CR59","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/epi.14083","volume":"59","author":"DL Nguyen","year":"2018","unstructured":"Nguyen DL, Wimberley C, Truillet C, Jego B, Caill\u00e9 F, Pottier G et al (2018) Longitudinal positron emission tomography imaging of glial cell activation in a mouse model of mesial temporal lobe epilepsy: toward identification of optimal treatment windows. Epilepsia 59(6):1234\u20131244. https:\/\/doi.org\/10.1111\/epi.14083","journal-title":"Epilepsia"},{"issue":"6","key":"3692_CR60","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s10571-020-00789-3","volume":"40","author":"X Chen","year":"2020","unstructured":"Chen X, Bao G, Liu F (2020) Inhibition of USP15 prevent glutamate-induced oxidative damage by activating Nrf2\/HO-1 signaling pathway in HT22 cells. Cell Mol Neurobiol 40(6):999\u20131010. https:\/\/doi.org\/10.1007\/s10571-020-00789-3","journal-title":"Cell Mol Neurobiol"},{"key":"3692_CR61","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.nbd.2013.07.015","volume":"59","author":"FM Noe","year":"2013","unstructured":"Noe FM, Polascheck N, Frigerio F, Bankstahl M, Ravizza T, Marchini S et al (2013) Pharmacological blockade of IL-1\u03b2\/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy. Neurobiol Dis 59:183\u2013193. https:\/\/doi.org\/10.1016\/j.nbd.2013.07.015","journal-title":"Neurobiol Dis"},{"issue":"5","key":"3692_CR62","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1093\/brain\/awy071","volume":"141","author":"T Shekh-Ahmad","year":"2018","unstructured":"Shekh-Ahmad T, Eckel R, Dayalan Naidu S, Higgins M, Yamamoto M, Dinkova-Kostova AT et al (2018) KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy. Brain 141(5):1390\u20131403. https:\/\/doi.org\/10.1093\/brain\/awy071","journal-title":"Brain"},{"issue":"8","key":"3692_CR63","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1111\/epi.16956","volume":"62","author":"M Di Nunzio","year":"2021","unstructured":"Di Nunzio M, Di Sapia R, Sorrentino D, Kebede V, Cerovic M, Gullotta GS et al (2021) Microglia proliferation plays distinct roles in acquired epilepsy depending on disease stages. Epilepsia 62(8):1931\u20131945. https:\/\/doi.org\/10.1111\/epi.16956","journal-title":"Epilepsia"},{"issue":"3","key":"3692_CR64","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s12035-018-1181-y","volume":"56","author":"J Pitsch","year":"2019","unstructured":"Pitsch J, Kuehn JC, Gnatkovsky V, M\u00fcller JA, van Loo KMJ, de Curtis M et al (2019) Anti-epileptogenic and anti-convulsive effects of fingolimod in experimental temporal lobe epilepsy. Mol Neurobiol 56(3):1825\u20131840. https:\/\/doi.org\/10.1007\/s12035-018-1181-y","journal-title":"Mol Neurobiol"},{"issue":"15","key":"3692_CR65","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12862-015-0511-1","volume":"26","author":"C Vlasschaert","year":"2015","unstructured":"Vlasschaert C, Xia X, Coulombe J, Gray DA (2015) Evolution fo the highly networked deubiquitinating enzymes US4, USP15 and USP11. BMC Evol Biol 26(15):230. https:\/\/doi.org\/10.1186\/s12862-015-0511-1","journal-title":"BMC Evol Biol"},{"issue":"7","key":"3692_CR66","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/ncb2522","volume":"14","author":"L Zhang","year":"2012","unstructured":"Zhang L, Zhou F, Drabsch Y, Gao R, Snaar-Jagalska BE, Mickanin C et al (2012) USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-\u03b2 type I receptor. Nat Cell Biol 14(7):717\u2013726. https:\/\/doi.org\/10.1038\/ncb2522","journal-title":"Nat Cell Biol"},{"issue":"9","key":"3692_CR67","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41388-021-01660-5","volume":"40","author":"C Meng","year":"2021","unstructured":"Meng C, Zhan J, Chen D, Shao G, Zhang H, Gu W et al (2021) The deubiquitinase USP11 regulates cell proliferation and ferroptotic cell death via stabilization of NRF2 USP11 deubiquitinates and stabilizes NRF2. Oncogene 40(9):1706\u20131720. https:\/\/doi.org\/10.1038\/s41388-021-01660-5","journal-title":"Oncogene"},{"issue":"6","key":"3692_CR68","doi-asserted-by":"publisher","first-page":"120063","DOI":"10.1098\/rsob.120063","volume":"2","author":"MA Al-Salihi","year":"2012","unstructured":"Al-Salihi MA, Herhaus L, Macartney T, Sapkota GP (2012) USP11 augments TGF\u03b2 signalling by deubiquitylating ALK5. Open Biol 2(6):120063. https:\/\/doi.org\/10.1098\/rsob.120063","journal-title":"Open Biol"},{"issue":"11","key":"3692_CR69","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1007\/s11064-017-2361-2","volume":"42","author":"X Jiang","year":"2017","unstructured":"Jiang X, Yu M, Ou Y, Cao Y, Yao Y et al (2017) Downregulation of USP4 promotes activation of microglia and subsequent neuronal inflammation in rat spinal cord after injury. Neurochem Res 42(11):3245\u20133253. https:\/\/doi.org\/10.1007\/s11064-017-2361-2","journal-title":"Neurochem Res"},{"issue":"12","key":"3692_CR70","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3390\/cells12121669","volume":"12","author":"P Bedner","year":"2023","unstructured":"Bedner P, Steinh\u00e4user C (2023) Role of impaired astrocyte gap junction coupling in epileptogenesis. Cells 12(12):1669. https:\/\/doi.org\/10.3390\/cells12121669","journal-title":"Cells"},{"issue":"12","key":"3692_CR71","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41582-022-00727-5","volume":"18","author":"A Vezzani","year":"2022","unstructured":"Vezzani A, Ravizza T, Bedner P, Aronica E, Steinh\u00e4user C et al (2022) Astrocytes in the initiation and progression of epilepsy. Nat Rev Neurol 18(12):707\u2013722. https:\/\/doi.org\/10.1038\/s41582-022-00727-5","journal-title":"Nat Rev Neurol"},{"issue":"Pt 5","key":"3692_CR72","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/brain\/awv067","volume":"138","author":"P Bedner","year":"2015","unstructured":"Bedner P, Dupper A, H\u00fcttmann K, M\u00fcller J, Herde MK et al (2015) Astrocyte uncoupling as a couse of human temporal lobe epilepsy. Brain 138(Pt 5):1208\u20131222. https:\/\/doi.org\/10.1093\/brain\/awv067","journal-title":"Brain"},{"issue":"2","key":"3692_CR73","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/glia.24265","volume":"71","author":"L Henning","year":"2023","unstructured":"Henning L, Antony H, Breuer A, M\u00fcller J, Seifert G et al (2023) Reactive microglia are the major source of tumor necrosis factor alpha and contribute to astrocyte dysfuntion and acute seizrues in experimental temporal lobe epilepsy. Glia 71(2):168\u2013186. https:\/\/doi.org\/10.1002\/glia.24265","journal-title":"Glia"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03692-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03692-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03692-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T04:38:34Z","timestamp":1711514314000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03692-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,24]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["3692"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03692-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2625841\/v1","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,24]]},"assertion":[{"value":"11 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal procedures were carried out in accordance with the European Community\u2019s Council Directive (2010\/63\/EU) and approved by the regional council (Regierungspr\u00e4sidium Freiburg, Approval number G19-33).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors gave their consent for publication of the article.No human participants were required for the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"JN, CV, CE, IK, CS, RF, PS, PG, LdM, JvE, and SD were employed at UCB Pharma at the time this study was performed. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}